Skip to main content

Lymphangiogenesis And Angiogenesis in Non-phymatous Rosacea

Our study evaluated the expression of vascular endothelial growth factor (VEGF), CD31 and D2-40 in involved and uninvolved skin of 18 patients with rosacea.

METHODS:
Immunostaining of facial skin specimens with VEGF, CD31 and D2-40 was compared between the lesional and the non-lesional skin of patients with erythemotelangiectatic and papulopustular rosacea.

RESULTS:
Significantly increased dermal expression of VEGF in lesional vs. non-lesional skin (88.9% and 55.6%) was observed. Dermal expression of CD31 and D2-40 was also increased in lesional vs. non-lesional skin.

There was no statistically significant difference in cutaneous expression of VEGF, CD31 and D2-40 between patients with papulopustular and erythemotelangiectatic rosacea, and no correlation was found between disease duration and immunoreactivity of VEGF, CD31or D2-40.

CONCLUSIONS:
Our study showed marked immunostaining of lesional skin with VEGF, CD31 and D2-40 compared with non-lesional skin. Increased immunoreactivity of D2-40 in lesional skin is interesting, given that none of the patients had facial edema.

There are no published data regarding the role of lymphangiogenesis in patients with non-phymatous rosacea; thus, our study represents a new understanding of its pathogenesis. Lack of correlation between D2-40 expression and disease duration suggests that lymphatics are involved early in the pathogenesis of rosacea and do not constitute a late event.


"Lymphangiogenesis and angiogenesis in non-phymatous rosacea"
Gomaa AH, Yaar M, Eyada MM, Bhawan J
J Cutan Pathol. 2007 Oct ; 34(10): 748-53 (Hubmed.org)



Highlight :
Treatment Of Rosacea | Acne Rosacea Antibiotic | Acne Rosacea | Rosacea Creams

Popular posts from this blog

1971 Innocenti Mini Cooper

1971 Innocenti Mini Cooper " An original Austin Mini Cooper. Not that strange, except I'm 6'4" and 260lbs. Would look kinda funny gettin in and out. _____ " Search Suggestion mk1forum net ̢ۢ view topic early navy blue 1275 gt seats Austin Cooper 998 Mk II 1969 Austin Mini Clubman 1970 Morris Mini Clubman 1275 GT 1971 Cooper S mk III replica 1971 Innocenti Cooper 1300 Export 1974 Morris mini 850 1976. http://mk1-forum.net/viewtopic.php?f=8&t=116 innocenti mini cooper flickr photo sharing After 1971 the production of Mini Coopers were continued in license in Italy by Innocenti as the Innocenti Mini Cooper 1300 and in Spain by Authi (Automoviles de Turismo Hispano . http://www.flickr.com/photos/ilmungo/26099568/ austin mini coopers for sale austin mini cooper classifieds In 1971, the 1275 cc Mini Cooper S was discontinued in the UK, leaving the Mini 1275GT as the only sporting Mini on sale for the rest of the decade. Innocenti in Italy . ht...

Azelaic acid in the treatment of papulopustular rosacea

To evaluate the clinical efficacy of topical 20% azelaic acid cream and 15% azelaic acid gel compared with their respective vehicles and metronidazole gel in the treatment of papulopustular rosacea . DATA SOURCES: Electronic searches of MEDLINE, EMBASE, BIOSIS, and SciSearch through July or August 2004 and the Cochrane Central Register of Controlled Trials through 2004 (issue 3). We performed hand searches of reference lists, conference proceedings, and clinical trial databases. Experts in rosacea and azelaic acid were contacted. STUDY SELECTION: Randomized controlled trials involving topical azelaic acid (cream or gel) for the treatment of rosacea compared with placebo or other topical treatments. Two authors independently examined the studies identified by the searches. Ten studies were identified, of which 5 were included (873 patients). DATA EXTRACTION: Two authors independently extracted data from the included studies, then jointly assessed methodological quality using a quality a...

Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea.

Curr Opin Otolaryngol Head Neck Surg. 2009 May 21; Brodsky JPURPOSE OF REVIEW: Patients commonly present to the otolaryngologist for management of benign facial lesions. It is important to be able to both recognize these lesions and offer patients the most effective therapies currently available. Advances in the understanding and management of three of the more common benign skin lesions affecting the face will be addressed in this review, with a particular emphasis on the most current therapeutic options for each lesion. RECENT FINDINGS: Actinic keratosis can now be treated with photodynamic therapy or with many topical agents, as alternatives to traditional surgical techniques. Seborrheic keratosis, as well as actinic keratosis and rosacea, are now often treated with laser therapy. In addition, rosacea management now includes nonantimicrobial topical agents, such as azelaic acid, and a wider armamentarium of systemic agents. SUMMARY: An understanding of these options will allow the ...